For instance, IGFBP-2 enhanced proliferation of androgen-independent prostate cancer cells [112] and IGF-I levels were found raised in serum and prostate tissue from PCa patients, being a predictor of risk for this type of cancer [113,114]. The gene discussed is IGFBP2; the disease is prostate carcinoma.